FYR Bio

About FYR Bio

FYR is a company focused on advancing precision medicine by decoding RNA and protein signals in blood through their proprietary technology. Their mission is to reveal insights beyond DNA to power better biomarkers, smarter clinical trials, and improved patient outcomes.

Products & Services

EV-Omics (EVO) Platform:An AI-enabled platform that profiles extracellular vesicles (EVs) in blood to provide multi-omic insights into disease mechanisms, transforming personalized patient care from screening to therapy monitoring.

SPARCS Technology:A proprietary technology that enriches disease-associated extracellular vesicles (EVs) in blood, solving signal-to-noise issues to unlock the potential of protein and RNA information for clearer molecular signals.

Specialties

Multi-omic Insights Extracellular Vesicles (EVs) Profiling AI-powered Analytics Biomarker Development Personalized Patient Care

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Venture Round T: - FT: Venture Round	A: 8000000 MR: - FA: $8 million FAN: 8000000	D: 2025-09-24 FD: 2025-09-24	3 investors

Venture Round Latest

2025-09-24

$8.0M

3 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

C

Chris Booth, Ph.D.

CEO & Board Member

S

Sarjubhai Patel

President & Board Member

K

Katie Havranek

Director, Research & Dev.

D

David Booth

Chief Operating Officer

B

Brian Conway

VP of Operations

A

Adam LaBonte

VP of Commercial Development

View 15 more team members with Pro

Unlock Full Team Directory

Recent News

FYR Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised